Pre-radiation chemotherapy for malignant glioma in adults

Canadian Journal of Neurological Sciences

Volumn 23, Issue 2, 1996, Pages 123-127

  Kirby, Sarah ^a   Macdonald, David ^b,c   Fisher, Barbara ^b,c   Gaspar, Laurie ^d   Cairncross, Gregory ^b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LONDON REGIONAL CANCER PROGRAM   (Canada)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROSOUREA;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0029991845     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100038841     Document Type: Article

References (17)

1. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993; 328: 1725-1731.
2. Pollack IF. Brain tumors in children. N Engl J Med 1994; 331: 1500-1507.
3. Macdonald DR, Gaspar LE, Cairncross JG. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 1990; 27: 573-574.
4. DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635-641.
5. Cairncross JG, Pexman JHW, Rathbone MP, Del Maestro RF. Post-operative contrast enhancement in brain tumor patients. Ann Neurol 1985; 17: 570-572.
6. Cairncross JG, Macdonald DR, Ludwin S, et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994; 12: 2013-2021.
7. Levin VA, Edwards MS, Wright DC, et al. Modified procarbazine, CCNU and vincristine (PCV-3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 1980; 64: 237-241.
8. Macdonald DR, Cascino TL, Schold SC, Cairncross JG. Response criteria for phase II studies of malignant glioma. J Clin Oncol 1990; 8: 1277-1280.
9. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978; 49: 333-343.
10. Archibald YM, Lunn D, Ruttan LA, et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 1994; 80: 247-253.
11. Winger MJ, Macdonald DR, Cairncross JG. Supratentorial anaplastic glioma in adults - prognostic importance of extent of resection and prior low grade glioma. J Neurosurg 1989; 71: 487-493.
12. Gaspar LE, Fisher BJ, Macdonald DR, et al. Malignant glioma - timing of response to radiation therapy. Int J Radiat Oncol Biol Phys 1993; 25: 877-879.
13. Glantz MJ, Burger PC, Herndon JE, et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991; 41: 1741-1744.
14. Watne K, Nome O, Hager B, Hirschberg H. Pre-radiation chemotherapy in glioma patients with poor prognosis factors. J Neuro-Oncol 1992; 13: 261-264.
15. Dropcho EJ, Rosenfeld SS, Morawetz RB, et al. Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. J Clin Oncol 1992; 10: 452-458.
16. Recht L, Fram RJ, Strauss G, et al. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-Platinum (CDDP) and i.v. BCNU: A phase II trial. Am J Clin Oncol 1990; 13: 125-131.
17. Bellamy A, Hill B. Interactions between clinically effective anti-tumor drugs and radiation in experimental systems. Biochim Biophys Acta 1984; 738: 125-166.